HomeRANI • NASDAQ
add
Rani Therapeutics Holdings Inc
Previous close
$2.62
Year range
$1.82 - $8.75
Market cap
139.93M USD
Avg Volume
50.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
NDAQ
0.00%
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.52M | -31.54% |
Net income | -6.80M | 26.85% |
Net profit margin | — | — |
Earnings per share | -0.26 | 29.73% |
EBITDA | -12.27M | 32.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 30.90M | -58.58% |
Total assets | 43.73M | -47.64% |
Total liabilities | 38.18M | 8.03% |
Total equity | 5.55M | — |
Shares outstanding | 29.29M | — |
Price to book | 23.82 | — |
Return on assets | -64.40% | — |
Return on capital | -69.01% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -6.80M | 26.85% |
Cash from operations | -9.03M | 26.60% |
Cash from investing | 6.52M | 727.00% |
Cash from financing | 141.00K | 76.25% |
Net change in cash | -2.36M | 79.33% |
Free cash flow | -8.37M | 25.13% |
About
Founded
2012
Headquarters
Website
Employees
140